During the last session, IGC Pharma Inc (AMEX:IGC)’s traded shares were 0.46 million, with the beta value of the company hitting 1.32. At the end of the trading day, the stock’s price was $0.33, reflecting an intraday loss of -3.41% or -$0.02. The 52-week high for the IGC share is $0.91, that puts it down -175.76 from that peak though still a striking 18.18% gain since the share price plummeted to a 52-week low of $0.27. The company’s market capitalization is $25.90M, and the average intraday trading volume over the past 10 days was 0.3 million shares, and the average trade volume was 364.24K shares over the past three months.
IGC Pharma Inc (IGC) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. IGC has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.03.
IGC Pharma Inc (AMEX:IGC) trade information
IGC Pharma Inc (IGC) registered a -3.41% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -3.41% in intraday trading to $0.33, hitting a weekly high. The stock’s 5-day price performance is -1.65%, and it has moved by -11.79% in 30 days. Based on these gigs, the overall price performance for the year is 26.06%. The short interest in IGC Pharma Inc (AMEX:IGC) is 1.22 million shares and it means that shorts have 2.29 day(s) to cover.
IGC Pharma Inc (IGC) estimates and forecasts
Statistics show that IGC Pharma Inc has outperformed its competitors in share price, compared to the industry in which it operates. IGC Pharma Inc (IGC) shares have gone down -28.57% during the last six months, with a year-to-date growth rate more than the industry average at 50.00% against 16.80. In the rating firms’ projections, revenue will decrease -12.04% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 204k as predicted by 1 analyst(s). Meanwhile, a consensus of 1 analyst(s) estimates revenue growth to 295k by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 204k and 295k respectively.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -13.79%. While earnings are projected to return 50.00% in 2025.
IGC Dividends
IGC Pharma Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
IGC Pharma Inc (AMEX:IGC)’s Major holders
IGC Pharma Inc insiders own 7.92% of total outstanding shares while institutional holders control 22.00%, with the float percentage being 23.89%. BLACKROCK INC. is the largest shareholder of the company, while 28.0 institutions own stock in it. As of 2024-06-30, the company held over 0.7 million shares (or 1.1961% of all shares), a total value of $0.31 million in shares.
The next largest institutional holding, with 0.65 million shares, is of VANGUARD GROUP INC’s that is approximately 1.0965% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $0.28 million.
Also, the Mutual Funds coming in first place with the largest holdings of IGC Pharma Inc (IGC) shares are Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund . Data provided on Sep 30, 2024 indicates that Vanguard Extended Market Index Fund owns about 630.22 shares. This amounts to just over 1.59 percent of the company’s overall shares, with a $0.21 million market value. The same data shows that the other fund manager holds slightly less at 384.72, or about 0.97% of the stock, which is worth about $0.13 million.
